Analysts' ratings for Alcon (NYSE: ALC) over the last quarter vary from bullish to bearish, as provided by 10 analysts. In the table below, you'll find a summary of their recent ratings, revealing the ...

Aug 20 (Reuters) - Shares in Alcon (ALCC.S), opens new tab fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on Tuesday flagging the impact of ...

Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Each year, more than 30 million people globally receive surgery to correct cataracts. As many people age, the crystalline lenses in their eyes become cloudy and obstruct their vision, but a simple and ...

Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in ...

Dr. Greg Moloney, MBBS, BSC MED, MMED, FRCSC, Ophthalmologist, explains what cataracts are and how they are corrected with intraocular lens surgery (IOL). Was Trump’s Venezuelan boat attack a ‘war ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and certain Envistar intraocular lens injector systems, according to the Food and ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S. Food ...